Heparin sodium
Heparin sodium is a pharmaceutical drug with 14 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
Enriched Heparin Anti COVID-19 Trial
Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung Transplantation
Clinical Trials (14)
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
Enriched Heparin Anti COVID-19 Trial
Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung Transplantation
A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
Bivalirudin vs Heparin in ECMO Patients
Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin
Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
The Effect of Heparinization Due to LBW
Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14